Cardinal Health
CAH
Delayed Nyse - 01/22 09:37:12 pm
73.3USD
+1.93%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period June 20172018
Sales129 976135 660
EBITDA2 9593 116
Operating profit (EBIT)2 7692 725
Pre-Tax Profit (EBT)--
Net income1 2881 150
EPS ( $ )4,033,32
Dividend per Share ( $ )1,851,87
Yield2,37%2,60%
Announcement Date08/02/2017
11:00am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period June 20172018
Debt3 5167 547
Finance--
Operating income (EBITDA)2 9593 116
Leverage
(Debt/EBITDA)
1,19x2,42x
Capital Expenditure387497
Book Value Per Share (BVPS)21,5 $21,8 $
Cash Flow per Share3,70 $8,07 $
Announcement Date08/02/2017
11:00am
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 22 667 M$ -
Entreprise Value (EV) 30 215 M$ 29 857 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 21,7x 16,4x
Capitalization / Revenue 0,17x 0,16x
EV / Revenue 0,22x 0,21x
EV / EBITDA 9,70x 8,90x
Yield (DPS / Price) 2,60% 2,74%
Price to book (Price / BVPS) 3,30x 3,00x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 2,01% 2,09%
operating Leverage (Delta EBIT / Delta Sales) - 2,16x
Net Margin (Net Profit / Revenue) 0,85% 0,99%
ROA (Net Profit / Asset) 4,80% 5,21%
ROE (Net Profit / Equities) 21,5% 23,4%
Rate of Dividend 56,2% 44,9%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   0,37% 0,37%
Cash Flow / Sales 1,87% 1,90%
Capital Intensity (Assets / Sales) 0,18x 0,19x
Financial Leverage (Net Debt / EBITDA) 2,42x 2,14x
Price Earning Ratio
BNA & Dividende